IDXX Lost 6.0% In A Day. Do You Buy Or Wait?
IDEXX Laboratories (IDXX) stock is down 6.0% in a day. Already own the stock? You might want to consider holding it. Planning to buy? This might be your opportunity. Consider the following data:
- A $52 Bil company with $4.0 Bil in revenue currently trading at $641.94.
- Last 12 month revenue growth of 6.7% and operating margin of 31.1%.
- Has Debt to Equity ratio of 0.0 and Cash to Assets ratio of 0.0
- Currently trading at P/E multiple of 52.4 and P/EBIT multiple of 40.9
- Has returned (median) 99.4% within a year following sharp dips since 2010. See IDXX Dip Buy Analysis.
While we like to buy dips if the fundamentals check out – for IDXX, see Buy or Sell IDXX Stock – we are wary of falling knives. Specifically, it is worth trying to answer if things get really bad, and IDXX drops another 20-30% to $449.36 levels, will we be able to hold on to the stock? What is the worst case scenario? We call it downturn resilience.
Below is a deep dive into IDEXX Laboratories (IDXX) downturn resilience – specifically, its performance vs the market during past crises? Turns out, the stock saw an impact slightly worse than the S&P 500 index during various economic downturns.
IDXX develops and distributes veterinary diagnostic products, instruments, consumables, and test kits for companion animals, livestock, poultry, dairy, and water quality testing markets.
2022 Inflation Shock
- IDXX stock fell 54.0% from a high of $705.76 on 5 August 2021 to $324.64 on 14 October 2022 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- The stock is yet to recover to its pre-Crisis high
- The highest the stock has reached since then is $682.78 on 4 August 2025 , and currently trades at $641.94
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -54.0% | -25.4% |
| # of Days for Full Recovery | Not Fully Recovered | 464 |
2020 Covid Pandemic
- IDXX stock fell 37.1% from a high of $290.97 on 19 February 2020 to $182.94 on 23 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 7 May 2020
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -37.1% | -33.9% |
| # of Days for Full Recovery | 45 | 148 |
2018 Correction
- IDXX stock fell 30.8% from a high of $254.46 on 29 August 2018 to $176.18 on 24 December 2018 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 24 May 2019
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -30.8% | -19.8% |
| # of Days for Full Recovery | 151 | 120 |
2008 Global Financial Crisis
- IDXX stock fell 57.3% from a high of $32.11 on 15 November 2007 to $13.72 on 20 November 2008 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 23 April 2010
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -57.3% | -56.8% |
| # of Days for Full Recovery | 519 | 1480 |
Worried that IDXX could fall much more? You could take a look at the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.